RSEKX — Victory RS Small Cap Growth Fund
Data updated: 2026-08-26
RSEKX — Victory RS Small Cap Growth Fund. United States Mid Cap Blend / Core Equity · $407.61M AUM. Holdings, fees, performance and SEC filings.
RSEKX Fund Overview
RSEKX — Victory RS Small Cap Growth Fund is a US mutual fund managed by Victory Portfolios, categorised as United States Mid Cap Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Victory Portfolios
- Category: United States Mid Cap Blend / Core Equity
- Assets under management: $407.61M
- 1-year return: 19.2%
- Ticker: RSEKX
- SEC CIK: 0000802716
- SEC series ID: S000053581
- Share class ID: C000168410
RSEKX Investment Objective and Strategy
Victory RS Small Cap Growth Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Victory Portfolios.
Investment objective
The Victory RS Small Cap Growth Fund (the Fund) seeks to provide long-term capital growth.
Principal investment strategy
The Adviser pursues the Funds investment objective by investing, under normal circumstances, at least 80% of its assets in small-capitalization companies. The Fund typically invests in equity securities of U.S. companies but may also invest any portion of its assets in foreign securities, including depositary receipts such as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The Adviser currently considers a company to be a small-capitalization company if its market capitalization (at the time of purchase) is less than $3 billion or 120% of the market capitalization of the largest company included in the Russell 2000 Index (the Index) (currently, approximately $41.0 billion, based on the size of the largest company in the Index on March 31, 2026), whichever is greater.
The size of companies in the Index changes with market conditions and the composition of the Index. The Adviser employs both fundamental analysis and quantitative screening in seeking to identify companies that the Adviser believes will produce sustainable earnings growth over a multi-year horizon. Investment candidates typically exhibit some or all of the following key criteria: strong organic revenue growth, expanding margins and profitability, innovative products or services, defensible competitive advantages, growing market share, and experienced management teams. The Adviser seeks to categorize each potential investment based on its view of a companys stage of development on a spectrum that identifies companies as promising, developing, or proven. Valuation is an integral part of the growth investment process.
Purchase decisions are based on the Advisers expectation of the potential reward relative to risk of each security based in part on the Advisers proprietary earnings calculations. The Adviser regularly reviews the Funds investments and will sell securities when the Adviser believes the securities are no longer attractive because (1) of a deterioration in rank of the security in accordance with the Advisers process, (2) of price appreciation, (3) of a change in the fundamental outlook of the company, or (4) other available investments are considered to be more attractive. As a result of the Advisers investment process, the Funds investments may be focused in one or more economic sectors from time to time, including the health care, industrials, and information technology sectors. As a result of its investment strategy, the Fund may experience annual portfolio turnover in excess of 100%.
RSEKX Holdings
Top 10 holdings of Victory RS Small Cap Growth Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Mercury Systems, Inc. | 2.87% |
| Esco Technologies Inc. | 2.11% |
| Msc Industrial Direct Co., Inc. | 2.07% |
| Semtech Corporation | 2.06% |
| Guardant Health, Inc. | 1.98% |
| Firstcash Holdings, Inc. | 1.98% |
| Revolution Medicines, Inc. | 1.93% |
| Riot Platforms, Inc. | 1.90% |
| Spyre Therapeutics Inc | 1.87% |
| Krystal Biotech Inc | 1.61% |
RSEKX Portfolio Allocation
Asset-class allocation of Victory RS Small Cap Growth Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.5% |
| Cash & Equivalents | 3.4% |
RSEKX Performance
Total returns for RSEKX (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 19.2% |
| 3 years (annualised) | -10.1% |
RSEKX Risk Information
Risk metrics for RSEKX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 21.7%
RSEKX Costs and Fees
RSEKX costs about $186 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.86%
- Gross expense ratio: 2.02%
- Portfolio turnover: 95%
- Brokerage commissions: 17.60 bps of average net assets (SEC N-CEN)
RSEKX Cashflows
Over the 12 months to 2026-06, Victory RS Small Cap Growth Fund had net outflows of $114.64M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | −$5.60M |
| 2026-05 | −$4.18M |
| 2026-04 | −$18.34M |
| 2026-03 | −$18.93M |
| 2026-02 | −$9.37M |
| 2026-01 | −$5.85M |
RSEKX Debt Constituents
No individual debt constituents are reported in Victory RS Small Cap Growth Fund's latest SEC N-PORT filing.
RSEKX Prospectus and SEC Filings
Official Victory RS Small Cap Growth Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-29
- Prospectus (485BPOS) — filed 2025-04-25
- Prospectus (485BPOS) — filed 2024-04-26
- Portfolio holdings (N-PORT) — filed 2026-08-26
- Portfolio holdings (N-PORT) — filed 2026-05-28
- Portfolio holdings (N-PORT) — filed 2026-02-27
- Annual census (N-CEN) — filed 2026-03-12
- Annual census (N-CEN) — filed 2025-03-13
Related Funds
Other United States Mid Cap Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.